Daily Dose - Mar 17th, 2026
Daily Dose |
View online
March 17, 2026
Lifecore expects 2026 revenue to decline by 12%-15% due to customer-driven factors
Guidance reflects customer loss due to change in its supply strategy, lower hyaluronic acid revenue from customer, and delayed customer launch that was slated for this year.
Read More
Almac Sciences adds cGMP flow hydrogenation capability for APIs
The new high-pressure technology is designed to improve reaction control, scalability, and safety for active pharmaceutical ingredient manufacturing.
Read More
Sartorius launches integrated platform for autologous cell therapy
The system is designed to increase manufacturing output while reducing costs and addressing key scalability bottlenecks, according to the company.
Read More
